Product
Apomorphine
Aliases
Apomorphine Cartridge, placebo
7 clinical trials
4 indications
Indication
Parkinson's diseaseIndication
Parkinson's DiseaseIndication
Apomorphine-induced Skin ReactionsClinical trial
A Randomized, Double-Blind, to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF EpisodesStatus: Terminated, Estimated PCD: 2024-02-28
Clinical trial
An Open-Label, Randomized, Crossover Trial Utilizing a Single-Blinded Rater to Evaluate APL-130277 Compared to Subcutaneous Apomorphine in Levodopa Responsive Subjects With Parkinson's Disease Complicated by Motor FluctuationsStatus: Completed, Estimated PCD: 2021-08-11
Clinical trial
Open-label Crossover Trial to Investigate the Efficacy of Treatments in Apomorphine-induced Skin ReactionsStatus: Terminated, Estimated PCD: 2018-12-31
Clinical trial
Pharmacokinetic Study of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease Under Stabilized Treatment.Status: Recruiting, Estimated PCD: 2024-09-16
Clinical trial
Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French HospitalsStatus: Completed, Estimated PCD: 2022-06-02
Clinical trial
Double Bind Randomized Placebo-controlled Cross-over Study to Evaluate Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's DiseaseStatus: Completed, Estimated PCD: 2021-01-31
Clinical trial
A Phase 3, Open-Label Study of the Safety, Efficacy and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson's Disease Patients With Unsatisfactory Control on Available TherapyStatus: Active (not recruiting), Estimated PCD: 2018-12-01